These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32448504)

  • 1. Metabolomics of a mouse model of preeclampsia induced by overexpressing soluble fms-like tyrosine kinase 1.
    Sato E; Tsunokuni Y; Kaneko M; Saigusa D; Saito R; Shimma S; Sekimoto A; Kawana Y; Oe Y; Ito S; Sato H; Takahashi N
    Biochem Biophys Res Commun; 2020 Jul; 527(4):1064-1071. PubMed ID: 32448504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia.
    Li F; Fushima T; Oyanagi G; Townley-Tilson HW; Sato E; Nakada H; Oe Y; Hagaman JR; Wilder J; Li M; Sekimoto A; Saigusa D; Sato H; Ito S; Jennette JC; Maeda N; Karumanchi SA; Smithies O; Takahashi N
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):13450-13455. PubMed ID: 27821757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethylamine N-Oxide increases soluble fms-like tyrosine Kinase-1 in human placenta via NADPH oxidase dependent ROS accumulation.
    Chang QX; Chen X; Ming-Xin Yang ; Zang NL; Li LQ; Zhong N; Xia LX; Huang QT; Zhong M
    Placenta; 2021 Jan; 103():134-140. PubMed ID: 33120049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.
    Jena MK; Sharma NR; Petitt M; Maulik D; Nayak NR
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model.
    Ushida T; Kotani T; Tsuda H; Imai K; Nakano T; Hirako S; Ito Y; Li H; Mano Y; Wang J; Miki R; Yamamoto E; Iwase A; Bando YK; Hirayama M; Ohno K; Toyokuni S; Kikkawa F
    Free Radic Biol Med; 2016 Dec; 101():524-533. PubMed ID: 27789293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia.
    Weel IC; Baergen RN; Romão-Veiga M; Borges VT; Ribeiro VR; Witkin SS; Bannwart-Castro C; Peraçoli JC; De Oliveira L; Peraçoli MT
    PLoS One; 2016; 11(6):e0157584. PubMed ID: 27315098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
    Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
    Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib restores angiogenic factor expression at the maternal-fetal interface in the BPH/5 mouse model of preeclampsia.
    Reijnders D; Liu CC; Xu X; Zhao AM; Olson KN; Butler SD; Douglas NC; Sones JL
    Physiol Genomics; 2018 May; 50(5):385-392. PubMed ID: 29521599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics Identifies Placental Dysfunction and Confirms Flt-1 (FMS-Like Tyrosine Kinase Receptor 1) Biomarker Specificity.
    Austdal M; Silva GB; Bowe S; Thomsen LCV; Tangerås LH; Bjørge L; Bathen TF; Iversen AC
    Hypertension; 2019 Nov; 74(5):1136-1143. PubMed ID: 31495279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Maternal Human sFLT1 Overexpression Leads to an Impaired Foetal Brain Development of Growth-Restricted Foetuses upon Experimental Preeclampsia.
    Vogtmann R; Burk LV; Serdar M; Kimmig R; Bendix I; Gellhaus A
    Oxid Med Cell Longev; 2022; 2022():3024032. PubMed ID: 35693702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
    Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
    Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine growth restriction, soluble fms-like tyrosine kinase-1 to placental growth factor ratio increase and preeclampsia.
    Boulanger H; Drouin D; Largilliere C; Lefèvre G
    J Gynecol Obstet Hum Reprod; 2019 Oct; 48(8):695-697. PubMed ID: 31085278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.
    Szalai G; Xu Y; Romero R; Chaiworapongsa T; Xu Z; Chiang PJ; Ahn H; Sundell B; Plazyo O; Jiang Y; Olive M; Wang B; Jacques SM; Qureshi F; Tarca AL; Erez O; Dong Z; Papp Z; Hassan SS; Hernandez-Andrade E; Than NG
    PLoS One; 2014; 9(11):e110867. PubMed ID: 25393290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Human sFLT1 in the Spongiotrophoblast Is Sufficient to Induce Placental Dysfunction and Fetal Growth Restriction in Transgenic Mice.
    Vogtmann R; Riedel A; Sassmannshausen I; Langer S; Kühnel-Terjung E; Kimmig R; Schorle H; Winterhager E; Gellhaus A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental-Specific Overexpression of sFlt-1 Alters Trophoblast Differentiation and Nutrient Transporter Expression in an IUGR Mouse Model.
    Kühnel E; Kleff V; Stojanovska V; Kaiser S; Waldschütz R; Herse F; Plösch T; Winterhager E; Gellhaus A
    J Cell Biochem; 2017 Jun; 118(6):1316-1329. PubMed ID: 27859593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia.
    Ehrlich L; Hoeller A; Golic M; Herse F; Perschel FH; Henrich W; Dechend R; Huppertz B; Verlohren S
    Hypertens Pregnancy; 2017 May; 36(2):175-185. PubMed ID: 28494189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.